1-20 of 5298
Journal Articles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exorcizing the devil of factor VIII inhibitors

Open Access
Paul C. Moorehead
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3716–3717.
https://doi.org/10.1182/bloodadvances.2025016643
Published: 2025
Journal Articles

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy

Open Access
Snegha Ananth, Nancy Eunice Torres, Bita Sahaf, Lekha Mikkilineni, Sebastian Fernandez-Pol, Darren Salmi, Robert Negrin, Parveen Shiraz, Melody Smith, Sushma Bharadwaj, Wen-Kai Weng, Vanessa E. Kennedy, Saurabh Dahiya, Lori Muffly, David Miklos, Matthew J. Frank, Hitomi Hosoya, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3832–3836.
https://doi.org/10.1182/bloodadvances.2025016346
Published: 2025
Includes: Supplemental data
Journal Articles

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

Open Access
Clinical Trials & Observations
Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp Staber, Paolo Mazzeo, Corinna Leng, David Böckle, Alexander Hölscher, Joseph Kauer, Natalia Rotter, Vladan Vucinic, Jakob Rudzki, David Nachbaur, Veit Bücklein, Ulf Schnetzke, Isabelle Krämer, Kai Wille, Alexander Hasse, Bastian von Tresckow, Mathias Hänel, Christian Koenecke, Giuliano Filippini Velazquez, Andreas Viardot, Christoph Schmid, Lorenz Thurner, Dominik Wolf, Marion Subklewe, Martin Dreyling, Peter Dreger, Sascha Dietrich, Ulrich Keller, Ulrich Jäger, Richard Greil, Thomas Pabst, Georg Lenz, Björn Chapuy
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3865–3877.
https://doi.org/10.1182/bloodadvances.2024014903
Published: 2025
Includes: Supplemental data
Journal Articles

PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome

Open Access
Clinical Trials & Observations
John M. Magenau, David G. Frame, Mary Riwes, John Maciejewski, Sarah Anand, Attaphol Pawarode, Anamarija M. Perry, Marcus Geer, Thomas Braun, Monalisa Ghosh, Pavan Reddy
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3878–3886.
https://doi.org/10.1182/bloodadvances.2024015200
Published: 2025
Includes: Supplemental data
Journal Articles

Recurrent thrombosis and major bleeding in children treated for VTE

Open Access
Stephanie F. Lenahan, Anne Blackmore, Matthew Fenchel, Evan Thomas, Joseph S. Palumbo, Cristina Tarango
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3824–3831.
https://doi.org/10.1182/bloodadvances.2025016135
Published: 2025
Journal Articles

Clec12a is required for the pathogenesis of NUP98::NSD1 AML

Open Access
Sagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, Courteney K. Lai, Basem Othman, Harish Sudarsanam, Thomas Eder, Florian Grebien, Daniel B. Lipka, Reinhard Henschler, Michael Heuser
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3887–3899.
https://doi.org/10.1182/bloodadvances.2024015739
Published: 2025
Includes: Supplemental data
Journal Articles

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

Open Access
Clinical Trials & Observations
Kari A. O. Tikkinen, Deborah M. Siegal, P. J. Devereaux, Sara V. Tornberg, Flavia K. Borges, Sandra Ofori, Jehonathan Pinthus, Bobby Shayegan, Lauri I. Lavikainen, Gordon H. Guyatt, Pavel S. Roshanov
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3837–3844.
https://doi.org/10.1182/bloodadvances.2024015515
Published: 2025
Journal Articles

A revised prognostic model for patients with acute myeloid leukemia and first relapse

Open Access
Niek G. van der Maas, Dimitri Breems, Clara P. W. Klerk, Thomas Pabst, Patrycja Gradowska, Abin Thomas, Bart J. Biemond, Jurgen Kuball, Catharina H. M. J. Van Elssen, Otto Visser, Marie-Christiane Vekemans, Carlos Graux, Johan Maertens, Steven Knapper, Mike Dennis, Sylvie Freeman, Ian Thomas, H. Berna Beverloo, Gerwin Huls, Charles Craddock, Peter J. M. Valk, Paresh Vyas, Nigel Russell, Gert Ossenkoppele, Bob Löwenberg, Jan J. Cornelissen, Jurjen Versluis
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3853–3864.
https://doi.org/10.1182/bloodadvances.2025015797
Published: 2025
Includes: Supplemental data
Journal Articles

Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism

Open Access
Axel Künstner, Vera von Kopylow, Philipp Lohneis, Matthias Kümmel, Hanno M. Witte, Lorenz Bastian, Veronica Bernard, Stephanie Stölting, Kathrin Kusch, Nikolas von Bubnoff, Konrad Steinestel, Annette Arndt, Hartmut Merz, Hauke Busch, Alfred C. Feller, Niklas Gebauer
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3900–3904.
https://doi.org/10.1182/bloodadvances.2025016002
Published: 2025
Includes: Supplemental data
Journal Articles

To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients

Open Access
Akshay Sharma, Tami John
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3845–3852.
https://doi.org/10.1182/bloodadvances.2024015413
Published: 2025
Journal Articles

The balancing act after pediatric venous thromboembolism

Open Access
Hilary Whitworth, Leslie Raffini
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3905–3906.
https://doi.org/10.1182/bloodadvances.2025016871
Published: 2025
Journal Articles

ESCALATing care? Eltrombopag in pediatric aplastic anemia

Open Access
Clinical Trials & Observations
Joshua Glass, Emma M. Groarke
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3819–3820.
https://doi.org/10.1182/bloodadvances.2025016872
Published: 2025
Journal Articles

Biomarker signatures for sickle cell pain

Open Access
Kalpna Gupta, Vidhya Kumaresan
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3821–3823.
https://doi.org/10.1182/bloodadvances.2025016707
Published: 2025
Journal Articles

Advancements in complement inhibition for PNH and primary complement–mediated thrombotic microangiopathy

Open Access
Clinical Trials & Observations
Thalia Padilla Kelley, Hannah King, Aditya Malhotra, Thomas G. DeLoughery, Kylee Martens, Joseph J. Shatzel
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3937–3945.
https://doi.org/10.1182/bloodadvances.2024015777
Published: 2025
Journal Articles

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

Open Access
Brandyn D. Lau, Aditya Bhave, Jennifer C. Yui, Rakhi Naik, Kathryn E. Dane, John Lindsley, Dauryne L. Shaffer, Peggy S. Kraus, Erik H. Hoyer, Elliott R. Haut, Michael B. Streiff
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3929–3936.
https://doi.org/10.1182/bloodadvances.2024015306
Published: 2025
Includes: Supplemental data
Journal Articles

PRIDE-FTG advances academic careers of underrepresented early-stage investigators performing blood disorders research

Open Access
Betty S. Pace, Oluwatoyosi A. Onwuemene, Athena Starlard-Davenport, Rhea-Beth Markowitz, Vahé Heboyan, Petar Datsov, Treva Rice
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3919–3928.
https://doi.org/10.1182/bloodadvances.2024015727
Published: 2025
Includes: Supplemental data
Journal Articles

Extramedullary plasmacytoma in children is a genetically distinct localized neoplasia curable by surgical resection

Open Access
Ilske Oschlies, Julia Richter, Amelie Alfert, Fernando Chahud, Stephanie Mueller, Ingrid Simonitsch-Klupp, Hannah von Mersi, Andishe Attarbaschi, Karoline Koch, Christoph Schaefers, Monika Brüggemann, Cecilia Bozzetti, Wilhelm Woessmann, Birgit Burkhardt, Wolfram Klapper
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3909–3918.
https://doi.org/10.1182/bloodadvances.2025016596
Published: 2025
Includes: Supplemental data
Journal Articles

Targeting PD-1 for HCT relapse: an immunologic knife’s edge

Open Access
Clinical Trials & Observations
Roman M. Shapiro, Robert J. Soiffer
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3907–3908.
https://doi.org/10.1182/bloodadvances.2025016709
Published: 2025
Journal Articles

Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial

Open Access
Clinical Trials & Observations
Florent Malard, Sylvain Thepot, Thomas Cluzeau, Martin Carré, Delphine Lebon, Pierre Bories, Ollivier Legrand, Marianne Schwarz, Michael Loschi, Mathieu Meunier, Magalie Joris, Cyrielle Gasc, Juliette Jouve, Benoît Levast, Emilie Plantamura, Emmanuel Prestat, Antoine Sabourin, Béatrice Gaugler, Joel Dore, Christian Récher, Mohamad Mohty
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3739–3749.
https://doi.org/10.1182/bloodadvances.2024015571
Published: 2025
Includes: Supplemental data
Journal Articles

Patient anti-FVIII drug antibodies bind preferentially to a subset of FVIII covalent states

Open Access
Diego Butera, Aster E. Pijning, Nathan G. Avery, Carmen H. Coxon, Clive Metcalfe, Angelina Mimoun, Sébastien Lacroix-Desmazes, Paul Clint Spiegel, Jr., Philip J. Hogg
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3706–3715.
https://doi.org/10.1182/bloodadvances.2025016474
Published: 2025
Includes: Supplemental data